Medical Research News

RSS

New research offers more insights into development of Kennedy's disease

Kennedy's disease leads to progressive muscle wastage. It is a condition that affects only men and it appears between 40 and 50 years of age. There is no specific treatment available.

13 Jun 2016

FDA approves Vaxchora for prevention of cholera

The U.S. Food and Drug Administration today approved Vaxchora, a vaccine for the prevention of cholera caused by serogroup O1 in adults 18 through 64 years of age traveling to cholera-affected areas. Vaxchora is the only FDA-approved vaccine for the prevention of cholera.

13 Jun 2016

U.S. study shows adults with diabetes born in 1940s living longer with less disability

Older Americans with diabetes born in the 1940s are living longer and with less disability performing day to day tasks than those born 10 years earlier, according to new research published in The Lancet Diabetes & Endocrinology journal.

13 Jun 2016

New controlled drug release system could revolutionize success rate of vascular bypasses

Coronary or peripheral bypasses are the most frequently performed vascular operations. Although one million patients per year and around the world, undergo this intervention, its failure rate reaches 50%, because of poor vessel healing, leading to vessel graft occlusion.

13 Jun 2016

New remedy for poor sleepers

Simon Fraser University research aimed at helping people get to sleep will be highlighted at an international sleep conference next week. Luc Beaudoin, an adjunct professor in cognitive science and education, created the mySleepButton app two years ago.

13 Jun 2016

Defects in cerebrospinal fluid flow may contribute to scoliosis during adolescence

A new study in zebrafish suggests that irregular fluid flow through the spinal column brought on by gene mutations is linked to a type of scoliosis that can affect humans during adolescence.

13 Jun 2016

ACCORDION study shows lowering blood glucose can reduce progression of diabetic retinopathy

People with type 2 diabetes who intensively controlled their blood sugar level during the landmark Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial Eye Study were found to have cut their risk of diabetic retinopathy in half in a follow-up analysis conducted four years after stopping intensive therapy.

13 Jun 2016

Controlling corneal blindness by 2030: an interview with Dr Pravin Vaddavalli

Corneal blindness is estimated to be the second most prevalent cause of blindness in many less developed countries. Globally, bilateral corneal blindness is estimated to afflict 4.9 million persons and accounts for 12% of 39 million blind, utilizing WHO 2010 global blindness data.

13 Jun 2016

Majority of mental health professionals believe firearm violence greater among mentally ill people

A new study finds that the majority of mental health professionals believe firearm safety issues are greater among mentally ill people, yet they do not screen their clients for firearms or provide firearm safety counseling.

12 Jun 2016

Findings may help explain why rheumatoid arthritis drugs vary in effect

Researchers at the University of California San Diego School of Medicine, with colleagues in Pennsylvania and China, report that not only are there distinct differences in key cellular processes and molecular signatures between rheumatoid arthritis (RA) and osteoarthritis (OA) but, more surprisingly, there are joint-specific differences in RA.

12 Jun 2016

Study finds link between depression, disease activity and disability in adolescents with JIA

European League Against Rheumatism Annual Congress confirmed a clear association between depression symptom severity and the level of disease activity and disability in adolescent patients with juvenile inflammatory arthritis.

12 Jun 2016

Liraglutide enhances high-dose insulin treatment in Type 2 diabetes

The addition of the glucagon-like peptide 1 receptor agonist liraglutide improves short-term outcomes and treatment satisfaction in patients who have uncontrolled Type 2 diabetes despite high doses of insulin, shows a randomised trial.

12 Jun 2016

Tandem myeloablative ASCT consolidation boosts neuroblastoma outcomes

Research presented at the American Society of Clinical Oncology annual conference suggests that consolidation therapy with tandem compared with single myeloablative autologous stem cell transplant can improve outcomes in paediatric patients with high-risk neuroblastoma.

12 Jun 2016

Individual patient meta-analysis supports tPA stroke benefits

The benefits of intravenous tissue plasminogen activator outweigh the risks in acute stroke patients treated within 4.5 hours of symptom onset, reports the Stroke Thrombolysis Trialists' Collaboration.

12 Jun 2016

Combining decongestion markers may guide HF hospital discharge

Patients hospitalised with acute heart failure who achieve good haemoconcentration in addition to a robust diuretic response are unlikely to be rehospitalised within the following 2 months, research suggests.

12 Jun 2016

ATACH-2 disputes intensive BP control benefits in acute ICH

Reducing systolic blood pressure to less than 140 mmHg has offered no benefits over standard care for patients with acute intracerebral haemorrhage in the ATACH-2 trial.

11 Jun 2016

CRP may guide vascular risk assessment in obese

Low C-reactive protein levels may identify obese people who are unlikely to develop cardiovascular complications over subsequent years, show data from the EPIC study.

11 Jun 2016

Immunoablation strengthens haemopoietic stem-cell transplantation effects in MS

Intensifying current transplant conditioning to remove rather than suppress immune cells ahead of autologous haematopoietic stem cell transplantation may result in long-term remission of multiple sclerosis, phase II trial findings show.

10 Jun 2016

About 30% of iPSCs not safe for clinical use, report multi-institutional researchers

As the promise of using regenerative stem cell therapies draws closer, a consortium of biomedical scientists reports about 30 percent of induced pluripotent stem cells they analyzed from 10 research institutions were genetically unstable and not safe for clinical use.

10 Jun 2016

Aspirin may increase likelihood of surviving colon cancer

It is well known that the drug ASA, also known internationally as Aspirin, has analgesic and fever-reducing properties. However, this drug may also increase the likelihood of surviving colon cancer.

10 Jun 2016

Medical Research News

New research offers more insights into development of Kennedy's disease

FDA approves Vaxchora for prevention of cholera

U.S. study shows adults with diabetes born in 1940s living longer with less disability

New controlled drug release system could revolutionize success rate of vascular bypasses

New remedy for poor sleepers

Defects in cerebrospinal fluid flow may contribute to scoliosis during adolescence

ACCORDION study shows lowering blood glucose can reduce progression of diabetic retinopathy

Controlling corneal blindness by 2030: an interview with Dr Pravin Vaddavalli

Majority of mental health professionals believe firearm violence greater among mentally ill people

Findings may help explain why rheumatoid arthritis drugs vary in effect

Study finds link between depression, disease activity and disability in adolescents with JIA

Liraglutide enhances high-dose insulin treatment in Type 2 diabetes

Tandem myeloablative ASCT consolidation boosts neuroblastoma outcomes

Individual patient meta-analysis supports tPA stroke benefits

Combining decongestion markers may guide HF hospital discharge

ATACH-2 disputes intensive BP control benefits in acute ICH

CRP may guide vascular risk assessment in obese

Immunoablation strengthens haemopoietic stem-cell transplantation effects in MS

About 30% of iPSCs not safe for clinical use, report multi-institutional researchers

Aspirin may increase likelihood of surviving colon cancer

The future of automation: Machine learning–driven hepatocyte and organoid counting

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Reimagining light scattering for biotherapeutics

Latest News